Healthcare Overbought Stocks: Pernix Therapeutics Holdings (NASDAQ:PTX), AVEO Pharmaceuticals (NASDAQ:AVEO), WellPoint Inc. (NYSE:WLP), Horizon Pharma (NASDAQ:HZNP)

Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) wants to start life with a new slate. It has taken several measures to wipe out the old issues. The company took care of two major worries. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) stock performance was 10.43% in last session and finished the day at $5.93. Traded volume was 1.14 million shares in the last session and the average volume of … Continue reading Healthcare Overbought Stocks: Pernix Therapeutics Holdings (NASDAQ:PTX), AVEO Pharmaceuticals (NASDAQ:AVEO), WellPoint Inc. (NYSE:WLP), Horizon Pharma (NASDAQ:HZNP)

Jason Knox03/2403/24

Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Palatin Technologies (NYSE:PTN) major shareholder Bvf Partners L. P/Il sold 540,181 shares of Palatin Technologies stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $1.14, for a total transaction of $615,806.34. Palatin Technologies, Inc. (NYSEMKT:PTN) stock performance was 17.07% in last session and finished the day at $1.44. Traded volume was 3.33 million shares in the last … Continue reading Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Jayne Crisman03/2403/24

Gilead Sciences GILD NASDAQ:GILD

Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases announced that Dan Mitchell has been appointed to the Company’s Board of Directors. Arca Biopharma Inc. (NASDAQ:ABIO) stock performance was -2.31% in last session and finished the day at $2.11. Traded volume was 3.15 million shares in the last session and the average volume of the stock remained 862,287.00 shares. The beta … Continue reading Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

Kevin Long03/1403/14

Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

Geron Corporation (NASDAQ:GERN) on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of imetelstat. Geron Corporation (NASDAQ:GERN) stock performance was 4.01% in last … Continue reading Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

John Bellich06/18

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of 1.57% from the company’s current price. Prosensa Holding NV (NASDAQ:RNA) … Continue reading Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis06/10

New Lows: ArQule, Inc. (NASDAQ:ARQL), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), TrovaGene Inc (NASDAQ:TROV)

ArQule, Inc (NASDAQ:ARQL) CEO Paolo Pucci purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 20th. The stock was purchased at an average cost of $1.42 per share, with a total value of $7,100.00. Following the transaction, the chief executive officer now directly owns 232,280 shares of the company’s stock, valued at approximately $329,838. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.76% … Continue reading New Lows: ArQule, Inc. (NASDAQ:ARQL), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), TrovaGene Inc (NASDAQ:TROV)

Mark Doerr05/27